Clinical Trial Update: Papilloma Virus Vaccine Therapy in Treating Young Patients With Recurrent Papilloma of the Larynx [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a papillomavirus vaccine therapy for young patients with recurrent laryngeal papillomatosis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Papillomatosis

Drugs mentioned

• Papillomavirus vaccine therapy

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Precancerous Condition | Phase 2 | Status: UNKNOWN